Med Page Today
MAY 24, 2024
(MedPage Today) -- For people with type 2 diabetes and chronic kidney disease (CKD), semaglutide (Ozempic) reduced the risk of major kidney events and death from cardiovascular causes, the phase III FLOW trial showed. Added to usual care, the.
Science Daily - Heart Disease
MAY 24, 2024
The stress of heart failure is remembered by the body and appears to lead to recurrent failure, along with other related health issues, according to new research. Researchers have found that heart failure leaves a 'stress memory' in the form of changes to the DNA modification of hematopoietic stem cells, which are involved in the production of blood and immune cells called macrophages.
HCPLive
MAY 24, 2024
Semaglutide 1.0 mg reduced major kidney disease events and slowed eGFR decline in patients with type 2 diabetes and chronic kidney disease, according to the FLOW trial.
ECG Guru
MAY 24, 2024
The Patient: A 78-year-old woman called emergency responders because she had palpitations. She was alert and oriented. Her BP was reported as being “stable”. We do not have information about her past medical history. We will update this post if we receive information about her outcome. ECG Number 1, 11:57 a.m.: There is a wide-complex tachycardia at a rate of about 230 bpm.
Cardiometabolic Health Congress
MAY 24, 2024
As we near the end of National Women’s Health Awareness Month, at CMHC , we want to bring attention to the important discussion of continuous glucose monitoring (CGM) during pregnancy and across the lifespan. CGM offers continuous, real-time glucose readings around the clock, surpassing traditional methods like HbA1C measurements and blood finger sticks.
Med Page Today
MAY 24, 2024
(MedPage Today) -- Note that some links may require registration or subscription. Also note that in observance of the Memorial Day holiday, our Morning Break feature will not appear on Monday. Look for its return on Tuesday, May 28. U.S. Representative.
Dr. Paddy Barrett
MAY 24, 2024
In the US, over 45% of the population has either diabetes or pre-diabetes 1. The absolute majority of those with diabetes have type 2 diabetes, which is usually associated with excess visceral fat and poor cardiometabolic health. This is not good. Why? Because a diagnosis of diabetes is very likely to shorten your life. A diagnosis of type 2 diabetes at age 30 can result in a 14 to 16-year shorter lifespan 2.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Becker's Hospital Review - Cardiology
MAY 24, 2024
Sulphur Springs, Texas-based Christus Health will expand its services and open a new cardiology location.
HCPLive
MAY 24, 2024
The panel offers expert perspectives on key factors that inform treatment decisions for patients with HIV.
American College of Cardiology
MAY 24, 2024
What is the relationship between aortic valve calcification (AVC) and aortic stenosis (AS) severity in patients with suspected low-flow low-gradient AS?
HCPLive
MAY 24, 2024
Igor Barjaktarevic, MD, PhD, provides insights on the evolving role of biomarkers in COPD, highlighting the role of eosinophils on informing treatment decisions.
American College of Cardiology
MAY 24, 2024
What is the prognostic value of microvascular resistance reserve (MRR) in patients with ST-segment elevation myocardial infarction (STEMI), and how does MRR compare with cardiac magnetic resonance (CMR) imaging parameters of microvascular resistance?
HCPLive
MAY 24, 2024
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.
American College of Cardiology
MAY 24, 2024
The goal of the FIRE trial was to evaluate multivessel revascularization guided by coronary physiology compared with culprit-only revascularization among elderly patients with acute myocardial infarction (MI) and multivessel coronary artery disease (CAD).
HCPLive
MAY 24, 2024
1) Nicola A. Hanania, MD, MS, discusses what we have learned from asthma research on the involvement of type 2 inflammation that is applicable to COPD.
DAIC
MAY 24, 2024
milla1cf Fri, 05/24/2024 - 07:00 May 24, 2024 — An artificial intelligence (AI) program developed by investigators in the Smidt Heart Institute and their Cedars-Sinai colleagues can detect a type of abnormal heart rhythm that can go unnoticed during medical appointments, according to a new study. The study’s findings, published in npj Digital Medicine , suggest AI could one day be employed to analyze images from a common imaging test called an echocardiogram, which uses sound waves to captur
HCPLive
MAY 24, 2024
ORION-8 demonstrates the consistent long-term efficacy and tolerability of twice-yearly inclisiran over a mean cumulative exposure of 3.7 years.
Physiologically Speaking
MAY 24, 2024
Greetings! Welcome to the Physiology Friday newsletter. Details about the sponsors of this newsletter including Examine.com and my book “VO2 Max Essentials ” can be found at the end of the post! Physiologically Speaking is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
HCPLive
MAY 24, 2024
Nigil Haroon, MD, PhD, explains how understanding the "window of opportunity" is crucial in treating axial spondyloarthritis.
American College of Cardiology
MAY 24, 2024
In this episode, Andrea Price, MS, AACC hosts Jill Steiner, MD, MS, FACC, and Rosy Thachil, MD, FACC for a discussion on the importance of social support and its role in promoting good mental health, especially among people with a chronic illness like heart disease.
HCPLive
MAY 24, 2024
Singh explains a potential new approach to the low FODMAP diet based on findings from research he presented at DDW suggesting a simplified step-up method.
American College of Cardiology
MAY 24, 2024
Is a novel modular pacing–defibrillator system, consisting of a leadless pacemaker in wireless communication with a subcutaneous implantable cardioverter–defibrillator (ICD), able to effectively and safely provide antitachycardia and bradycardia pacing?
HCPLive
MAY 24, 2024
Aby describes findings from a pair of studies presented at DDW exploring the prevalence and impact of financial burden in liver transplant candidates.
American College of Cardiology
MAY 24, 2024
The goal of the RENOVATE-COMPLEX-PCI trial was to evaluate intravascular imaging-guided percutaneous coronary intervention (PCI) compared with angiography-guided PCI among patients with complex coronary artery disease.
HCPLive
MAY 24, 2024
Aflibercept 8 mg exhibited clinically meaningful visual, anatomic improvements at Week 48 in patients with DME regardless of baseline visual acuity.
The American Journal of Cardiology
MAY 24, 2024
Publication date: Available online 23 May 2024 Source: The American Journal of Cardiology Author(s): Sina Kazemian, Kannu Bansal, Toshiki Kuno, Tanush Gupta, Kashish Goel, Sahil Khera, Mohamad Alkhouli, Dhaval Kolte
HCPLive
MAY 24, 2024
New study finds SGLT2 inhibitors reduce proteinuria in IgA nephropathy, with greater initial eGFR dips predicting stronger treatment responses.
The British Journal of Cardiology
MAY 24, 2024
Designed to give healthcare professionals an understanding of the epidemiology and pathophysiology of heart failure (HF). It is one of several modules in our heart failure programme.
HCPLive
MAY 24, 2024
Lacy reviews key considerations for the diagnostic evaluation and treatment of abdominal bloating and distension based on his session at DDW.
The British Journal of Cardiology
MAY 24, 2024
Introduction The aims of chronic heart failure (HF) management are: to provide symptom relief to prevent hospitalisation for HF to improve survival. Optimal pharmacological and non-pharmacological management (including device treatment) have had an enormous beneficial impact on the clinical course of HF. This module will focus on lifestyle modifications and pharmacological treatment.
HCPLive
MAY 24, 2024
Age, chronic comorbidities, and COVID-19 vaccination status in patients with IMIDs serve as risk factors for severe COVID-19 outcomes.
Frontiers in Cardiovascular Medicine
MAY 24, 2024
BackgroundST-segment elevation myocardial infarction (STEMI) persists to be prevalent in the elderly with a dismal prognosis. The capacity of endothelial progenitor cells (EPCs) is reduced with aging. Nevertheless, the influence of aging on the functionality of EPCs in STEMI is not fully understood.MethodThis study enrolled 20 younger STEMI patients and 21 older STEMI patients.
HCPLive
MAY 24, 2024
Combining algorithms SCORE2 and QRISK3 created the best predictive model to predict the cardiovascular risk for patients with PsA.
The British Journal of Cardiology
MAY 24, 2024
Designed to give healthcare professionals an understanding of the clinical significance and treatment of electrolyte abnormalities and anaemia in patients with heart failure.
HCPLive
MAY 24, 2024
Experts on the treatment of HIV discuss how they talk with their patients about adverse effects associated with HIV regimens.
The British Journal of Cardiology
MAY 24, 2024
Designed to give healthcare professionals an understanding of surgical methods to manage heart failure. It is one of several modules in our heart failure programme.
HCPLive
MAY 24, 2024
Study finds roxadustat effectively treats anemia in both dialysis-dependent and non-dialysis-dependent CKD patients.
Expert insights. Personalized for you.
116 
Let's personalize your content